Skip to main content
NIH funding notice RFA-MH-16-220

Novel Assays to Address Translational Gaps in Treatment Development (UH2/UH3)

Closed on April 3, 2015.

Posted
January 12, 2015
Close date
April 3, 2015
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,273,810 in first-year total cost, median $636,905.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-C (08)]2

Most frequent institutions

  1. MCLEAN HOSPITAL1
  2. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
Competing awards under RFA-MH-16-220 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2016Novel Cross-Species Neurophysiological Assays of Reward and Cognitive Domains1UH2MH109334-01PIZZAGALLI, DIEGO AMCLEAN HOSPITAL, MA$770,580ZMH1
2016Neurophysiological biomarkers of behavioral dimensions from cross-species paradigms1UH2MH109168-01YOUNG, JARED WILLIAMUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$503,230ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.